Anti-inflammatory potential of 2-styrylchromones regarding their interference with arachidonic acid metabolic pathways

Biochemical Pharmacology

Volumn 78, Issue 2, 2009, Pages 171-177

  Gomes, Ana ^a   Fernandes, Eduarda ^a   Silva, Artur M S ^b   Pinto, Diana C G A ^b   Santos, Clementina M M ^b,c   Cavaleiro, José A S ^b   Lima, José L F C ^a  

^a Campus Universitário de Santiago   (Portugal)

^b UNIVERSITY OF AVEIRO   (Portugal)

^c INSTITUTO POLITÉCNICO DE BRAGANÇA   (Portugal)

Author keywords

2 Styrylchromones; 5 Lipoxigenase; Cyclooxygenase; Dual inhibitors; Inflammation; Leukotriene B4

Indexed keywords

2 STYRYLCHROMONE DERIVATIVE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; CHELATING AGENT; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; FLAVONE DERIVATIVE; LEUKOTRIENE B4; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARACHIDONIC ACID METABOLISM; ARTICLE; CHELATION; CYTOTOXICITY; DRUG MECHANISM; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONIC ACID; CELL SURVIVAL; CHROMONES; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; HUMANS; LEUKOCYTES, MONONUCLEAR; METABOLIC NETWORKS AND PATHWAYS; STYRENES;

EID: 67349237764     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2009.03.028     Document Type: Article

References (51)

1. Kam P.C.A., and See A.U.L. Cyclo-oxygenase isoenzymes: physiological and pharmacological role. Anaesthesia 55 (2000) 442-449
2. Cipollone F., Cicolini G., and Bucci M. Cyclooxygenase and prostaglandin synthases in atherosclerosis: recent insights and future perspectives. Pharmacol Ther 118 (2008) 161-180
3. Wang M.T., Honn K.V., and Nie D. Cyclooxygenases, prostanoids, and tumor progression. Cancer Metastasis Rev 26 (2007) 525-534
4. Davies P., Bailey P.J., Goldenberg M.M., and Fordhutchinson A.W. The rsole of Arachidonic-acid oxygenation products in pain and inflammation. Annu Rev Immunol 2 (1984) 335-357
5. Vane J.R., and Botting R.M. Anti-inflammatory drugs and their mechanism of action. Inflamm Res 47 Suppl. 2 (1998) S78-S87
6. Jampilek J., Dolezal M., Opletalova V., and Hartl J. 5-lipoxygenase, leukotrienes biosynthesis and potential antileukotrienic agents. Curr Med Chem 13 (2006) 117-129
7. Powell W.S., Gravelle F., and Gravel S. Metabolism of 5(S)-Hydroxy-6,8,11,14-Eicosatetraenoic acid and other 5(S)-hydroxyeicosanoids by a specific dehydrogenase in human polymorphonuclear leukocytes. J Biol Chem 267 (1992) 19233-19241
8. Samuelsson B., Dahlen S.E., Lindgren J.A., Rouzer C.A., and Serhan C.N. Leukotrienes and Lipoxins - structures, biosynthesis, and biological effects. Science 237 (1987) 1171-1176
9. Busse W.W. Leukotrienes and inflammation. Am J Respir Crit Care Med 157 (1998) S210-S213
10. Stamatiou P., Hamid Q., Taha R., Yu W.G., Issekutz T.B., Rokach J., et al. 5-oxo-ETE induces pulmonary eosinophilia in an integrin-dependent manner in brown Norway rats. J Clin Invest 102 (1998) 2165-2172
11. Sharma J.N., and Mohammed L.A. The role of leukotrienes in the pathophysiology of inflammatory disorders: is there a case for revisiting leukotrienes as therapeutic targets?. Inflammopharmacology 14 (2006) 10-16
12. Werz O., and Steinhilber D. Therapeutic options for 5-lipoxygenase inhibitors. Pharmacol Ther 112 (2006) 701-718
13. Khanapure S.P., Garvey D.S., Janero D.R., and Letts L.G. Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers. Curr Top Med Chem 7 (2007) 311-340
14. Bertolini A., Ottani A., and Sandrini M. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks. Curr Med Chem 9 (2002) 1033-1043
15. Gerwick W.H., Lopez A., Van Dyune G.D., Clardy J., Ortiz W., and Baez A. Hormothamnione, a novel cytotoxic styrylchromone from the marine cyanophyte Hormothamnion enteromorphoides grunow. Tetrahedron Lett 27 (1986) 1979-1982
16. Gerwick W.H. 6-Desmethoxyhormothamnione, a new cytotoxic styrylchromone from the marine cryptophyte Chrysophaeum taylori. J Nat Prod 52 (1989) 252-256
17. Doria G., Romeo C., Forgione A., Sberze P., Tibolla N., Corno M.L., et al. Antiallergic agents. III. Substituted trans-2-ethenyl-4-oxo-4H-1-benzopyran-6-carboxylic acids. Eur J Med Chem 14 (1979) 347-351
18. Desideri N., Conti C., Mastromarino P., and Mastropaolo F. Synthesis and anti-rhinovirus activity of 2-styrylchromones. Antivir Chem Chemother 11 (2000) 373-381
19. Brion D., Le Baut G., Zammatio F., Pierre A., Atassi G., and Belachm L. Preparation of 2-styryl-4-chromanones as anticancer agents. European patent application EP 454:587. Chem Abstr 116 (1991) 106092k
20. Karton Y., Jiang J.L., Ji X.D., Melman N., Olah M.E., Stiles G.L., et al. Synthesis and biological activities of flavonoid derivatives as A3 adenosine receptor antagonists. J Med Chem 39 (1996) 2293-2301
21. Fernandes E., Carvalho F., Silva A.M.S., Santos C.M.M., Pinto D.C.G.A., Cavaleiro J.A.S., et al. 2-Styrylchromones as novel inhibitors of xanthine oxidase. A structure-activity study. J Enzyme Inhib Med Chem 17 (2002) 45-48
22. Fernandes E., Carvalho M., Carvalho F., Silva A.M.S., Santos C.M.M., Pinto D.C.G.A., et al. Hepatoprotective activity of polyhydroxylated 2-styrylchromones against tert-butylhydroperoxide induced toxicity in freshly isolated rat hepatocytes. Arch Toxicol 77 (2003) 500-505
23. Filipe P., Silva A.M., Morliere P., Brito C.M., Patterson L.K., Hug G.L., et al. Polyhydroxylated 2-styrylchromones as potent antioxidants. Biochem Pharmacol 67 (2004) 2207-2218
24. Gomes A., Fernandes E., Silva A.M., Santos C.M., Pinto D.C., Cavaleiro J.A., et al. 2-Styrylchromones: novel strong scavengers of reactive oxygen and nitrogen species. Bioorg Med Chem 15 (2007) 6027-6036
25. Werz O. Inhibition of 5-lipoxygenase product synthesis by natural compounds of plant origin. Planta Med 73 (2007) 1331-1357
26. Santos C.M.M., Silva A.M.S., and Cavaleiro J.A.S. Synthesis of new hydroxy-2-styrylchromones. Eur J Org Chem 2003 (2003) 4575-4585
27. Baker W. Molecular rearrangement of some o-acyloxyacetophenones and the mechanism of the production of 3-acylchromones. J Chem Soc (1933) 1381-1389
28. Mahal H.S., and Venkataraman K. Synthetical experiments in the chromone group. Part XIV. The action of sodamide on 1-acyloxy-2-acetonaphthones. J Chem Soc (1934) 1767-1769
29. Price W.A., Silva A.M.S., and Cavaleiro J.A.S. 2-Styrylchromones - biological action, synthesis and Reactivity. Heterocycles 36 (1993) 2601-2612
30. Costa D., Marques A.P., Reis R.L., Lima J.L.F.C., and Fernandes E. Inhibition of human neutrophil oxidative burst by pyrazolone derivatives. Free Radic Biol Med 40 (2006) 632-640
31. Mathew S., and Abraham T.E. In vitro antioxidant activity and scavenging effects of Cinnamomum verum leaf extract assayed by different methodologies. Food Chem Toxicol 44 (2006) 198-206
32. Guo M., Perez C., Wei Y., Rapoza E., Su G., Bou-Abdallah F., et al. Iron-binding properties of plant phenolics and cranberry's bio-effects. Dalton Trans (2007) 4951-4961
33. Yoshimoto T., Furukawa M., Yamamoto S., Horie T., and Watanabe-Kohno S. Flavonoids: potent inhibitors of arachidonate 5-lipoxygenase. Biochem Biophys Res Commun 116 (1983) 612-618
34. Redrejo-Rodriguez M., Tejeda-Cano A., Pinto M.D., and Macias P. Lipoxygenase inhibition by flavonoids: semiempirical study of the structure-activity relation. J Mol Struct-Theochem 674 (2004) 121-124
35. Silva A.M.S., Pinto D., Tavares H.R., Cavaleiro J.A.S., Jimeno M.L., and Elguero J. Novel (E)- and (Z)-2-styrylchromones from (E,E)-2'-hydroxycinnamylideneacetophenones - xanthones from daylight photooxidative cyclization of (E)-2-styrylchromones. Eur J Org Chem 1998 (1998) 2031-2038
36. Mira L., Fernandez M.T., Santos M., Rocha R., Florencio M.H., and Jennings K.R. Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity. Free Radic Res 36 (2002) 1199-1208
37. Selvam C., Jachak S.M., and Bhutani K.K. Cyclooxygenase inhibitory flavonoids from the stem bark of Semecarpus anacardium Linn. Phytother Res 18 (2004) 582-584
38. Gomes A., Fernandes E., Lima J.L., Mira L., and Corvo M.L. Molecular mechanisms of anti-inflammatory activity mediated by flavonoids. Curr Med Chem 15 (2008) 1586-1605
39. Rosenkranz H.S., and Thampatty B.P. SAR: flavonoids and COX-2 inhibition. Oncol Res 13 (2003) 529-535
40. Dannhardt G., and Laufer S. Structural approaches to explain the selectivity of COX-2 inhibitors: is there a common pharmacophore. Curr Med Chem 7 (2000) 1101-1112
41. Antman E.M., DeMets D., and Loscalzo J. Cyclooxygenase inhibition and cardiovascular risk. Circulation 112 (2005) 759-770
42. Solomon D.H. Selective cyclooxygenase 2 inhibitors and cardiovascular events. Arthritis Rheum 52 (2005) 1968-1978
43. Grosser T., Fries S., and FitzGerald G.A. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest 116 (2006) 4-15
44. Fiorucci S., Meli R., Bucci M., and Cirino G. Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy?. Biochem Pharmacol 62 (2001) 1433-1438
45. Vancheri C., Mastruzzo C., Sortino M.A., and Crimi N. The lung as a privileged site for the beneficial actions of PGE(2). Trends Immunol 25 (2004) 40-46
46. Harizi H., Juzan M., Pitard V., Moreau J.F., and Gualde N. Cyclooxygenase-2-issued prostaglandin E-2 enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. J Immunol 168 (2002) 2255-2263
47. Serhan C.N. Resolution phase of inflammation: Novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol 25 (2007) 101-137
48. Hudson N., Balsitis M., Everitt S., and Hawkey C.J. Enhanced gastric-mucosal leukotriene-B(4) synthesis in patients taking nonsteroidal antiinflammatory drugs. Gut 34 (1993) 742-747
49. Fernandes E., Toste S.A., Lima J., and Reis S. The metabolism of sulindac enhances its scavenging activity against reactive oxygen and nitrogen species. Free Radic Biol Med 35 (2003) 1008-1017
50. Fernandes E., Costa D., Toste S.A., Lima J.L.F.C., and Reis S. In vitro scavenging activity for reactive oxygen and nitrogen species by nonsteroidal anti-inflammatory indole, pyrrole, and oxazole derivative drugs. Free Radic Biol Med 37 (2004) 1895-1905
51. Costa D., Vieira A., and Fernandes E. Dipyrone and aminopyrine are effective scavengers of reactive nitrogen species. Redox Rep 11 (2006) 136-142